Scienmag

OCTOBER 6, 2020

Three ongoing influenza vaccine cardiovascular outcomes trials could hold insights into testing novel interventions against COVID-19 Seasonal influenza vaccine development and mass production, as well as three international influenza vaccine cardiovascular outcomes trials currently underway, may inform future efforts targeted at developing and evaluating (..)

Vaccine 40

Vaccine Vaccination Trials Production 40

Scienmag

FEBRUARY 12, 2021

Health policy statement recommends priority vaccination for specific heart disease patient populations not specified in CDC distribution guidance COVID-19 vaccine prioritization should prioritize those with advanced cardiovascular (CVD) disease over well-managed CVD disease, according to an American College of Cardiology (ACC) health policy statement (..)

Cardiology 54

Cardiology Vaccine Vaccination Medicine 54

Medical Xpress

NOVEMBER 21, 2022

A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, especially after the second mRNA-1273 (Moderna) vaccine, suggesting that vaccine type, age and sex should be considered when vaccinating. The study is published in CMAJ (Canadian Medical Association Journal).

Vaccine 75

Vaccine Vaccination Cardiology 75

Medical Xpress

NOVEMBER 7, 2022

People with heart disease who forego annual flu vaccination for fear of having an adverse reaction may wish to reconsider. New research finds individuals with high-risk heart disease who experience mild to moderate side effects are less likely to be hospitalized for heart or lung problems or die from any cause.

Vaccine 74

Vaccine Vaccination Research Cardiology 74

Pharmaceutical Technology

JUNE 14, 2023

We are confident that bringing these assets into our portfolio will strengthen Blue Water’s financial position, allow us to advance our robust vaccine pipeline, and help millions of patients around the world receive proper access to critical treatments,” said Hernandez. The agreement includes an $8.5m

FDA Approval 130

FDA Approval Cardiology Marketing Vaccine 130

pharmaphorum

MARCH 15, 2022

Major societies such as the European Society of cardiology (ESC) reported a 177% increase in attendees for its 2020 annual congress : 77,350 virtual attendees (logged-on) 2020 cf 27,946 physical attendees 2019. yes, if vaccines are available; 15.8% One important caveat here is that delegate registration fees were waived.

Doctors 105

Doctors Doctor Cardiology Allergies 105

STAT News

JULY 14, 2022

Can CRISPR edit out a heart attack? What happens on #GutTok? And is health care recession-proof? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

Life Science 98

Life Science Genome Genomics Cardiology 98

Scienmag

MARCH 23, 2021

Credit: Stephanie King/Michigan Medicine (the academic medical center of the University of Michigan) People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study.

Medicine 97

Medicine Allergies Cardiology Vaccination 97

Scienmag

NOVEMBER 17, 2020

17, 2020 — People with heart disease can receive either the high-dose or standard-dose flu vaccines for protection from heart or lung-related deaths or hospitalizations, according to late breaking research presented today at the American Heart Association’s Scientific Sessions 2020. 08) DALLAS, Nov.

Vaccine 46

Vaccine Vaccination Research Cardiology 46

Scienmag

AUGUST 28, 2020

Sophia Antipolis, France – 28 Aug 2020: Influenza and pneumonia vaccinations are associated with fewer hospital deaths in patients with heart failure. That’s the result of a study in nearly 3 million Americans released today at ESC Congress 2020.1 One out of five individuals will develop heart failure in their lifetime.

Vaccine 40

Vaccine Vaccination Development Cardiology 40

Velocity Clinical Research

MARCH 19, 2024

The summit focused on Velocity’s Diabetes + Obesity, MASH, Vaccine, Cardiology, and Women’s Health CARE Councils, along with a few areas in development. Each CARE Council comprises key opinion leaders, Principal Investigators, and operational experts from Velocity sites worldwide.

Cardiology 52

Cardiology Clinical Trials Clinical Trials Clinical Development 52

The Pharma Data

MARCH 13, 2022

We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines.

Dermatology 52

Dermatology Cardiology Development Medicine 52

Scienmag

OCTOBER 15, 2020

New call to action highlights dual threat of influenza and COVID-19 for US adults with chronic health conditions Washington, DC (October 15, 2020) — The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, (..)

Allergies 47

Allergies Cardiology Vaccination Vaccine 47

Medical Xpress

JANUARY 19, 2023

CLAIM: British telephone booths are being retrofitted with defibrillators because the COVID-19 vaccines are causing more cardiac arrests.

Vaccine 52

Vaccine Vaccination Cardiology 52

Scienmag

APRIL 30, 2022

The ground-breaking research is presented today at Frontiers in CardioVascular Biomedicine 2022, a scientific congress of the European Society of Cardiology (ESC).1 Budapest, Hungary – 30 April 2022: A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack.

Cardiology 82

Cardiology Vaccine Vaccination Genetics 82

Eye on FDA

MARCH 26, 2021

The last in-person meeting of an advisory committee – by coincidence a meeting of the Vaccines and Related Biological Products Advisory Committee – occurred on March 4, 2020. I recently attended all three Vaccines and Related Biological Products Advisory Committee meetings on the COVID-19 vaccine candidates.

Vaccine 96

Vaccine Vaccination Cardiology Gene Therapy 96

The Pharma Data

SEPTEMBER 15, 2020

Major revenue contributions through 2025 anticipated from Oncology, Vaccines, Rare Disease and Inflammation and Immunology. New stability, immunogenicity, and tolerability data for COVID-19 vaccine candidate, BNT162b2, presented. BNT162 mRNA-based Vaccine Program.

Gene Therapy 52

Gene Therapy Vaccine Vaccination Trials 52

The Pharma Data

MARCH 23, 2022

Under his leadership, Merck has become a leading oncology company and achieved more than 140 medicine and vaccine approvals globally across numerous therapeutic areas. In his new role Dr. Barr will lead all late-stage clinical development for Merck’s expansive human health portfolio and pipeline and will report to Dr. Li.

Clinical Development 52

Clinical Development Development Vaccine Vaccination 52

pharmaphorum

FEBRUARY 26, 2021

This move revolutionised cardiology – coronary stents keep vessels open so blood can flow to the heart. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government.

Sales 126

Sales Production Pharma Companies Marketing 126

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. billion in 2022. for a pediatric dose.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

APRIL 12, 2021

Lead investigator Mikhail Kosiborod of Saint Luke’s said that while the result was disappointing “the findings are very interesting and valuable, and will inform future clinical science” The data will be presented in full next month at the American College of Cardiology (ACC) congress.

Cardiology 85

Cardiology Antibody Trials Drugs 85

Rethinking Clinical Trials

SEPTEMBER 22, 2022

Professor in Translational Cardiology and Pragmatic Randomized Trials. Head of Center for Translational Cardiology and Pragmatic Randomized Trials. Department of Cardiology. The NUDGE-FLU trial is a nationwide implementation study that will randomize all Danish citizens above 65 who receive a free vaccine by Danish government.

Trials 100

Trials Cardiology Vaccine Vaccination 100

pharmaphorum

JANUARY 5, 2021

Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at. These changes are likely to reduce only slowly in the Vaccine+ environment, and will not be entirely reversed.

Sales 105

Sales Marketing Production Vaccination 105

The Pharma Data

MARCH 31, 2022

Additionally, Janssen is sponsoring the American College of Cardiology Foundation’s “Change the FIELD” initiative, a major multi-year effort to foster inclusivity, equity, leadership and diversity in the field of cardiology. About the Janssen Pharmaceutical Companies of Johnson & Johnson. Source link: [link].

Cardiology 52

Cardiology Research Medicine Vaccine 52

The Pharma Data

DECEMBER 1, 2020

14 in JAMA Cardiology to coincide with the American Heart Association Scientific Sessions 2020, held virtually from Nov. AHA: Young Adults With CVD Have Low Flu Vaccination Rates. TUESDAY, Nov. Read Full Text. AHA Meeting Addresses Latest Research, COVID-19, Health Care Disparities. TUESDAY, Nov. Read Full Text. TUESDAY, Nov.

Medicine 52

Medicine Research Cardiology Vaccine 52

The Pharma Data

FEBRUARY 24, 2022

Director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

FDA Approval 52

FDA Approval Cardiology Cosmetics Production 52

The Pharma Data

APRIL 26, 2021

Furthermore, Novartis joined industry-wide efforts to meet global demand for COVID-19 vaccines and therapeutics. An initial agreement was signed to leverage Novartis manufacturing capacity and capabilities to support the production of the Pfizer-BioNTech vaccine (Comirnaty ), with production planned to start in the second quarter of 2021.

Sales 40

Sales Medicine Production Manufacturing 40

The Pharma Data

OCTOBER 27, 2021

Hal’s expertise in some of the most exciting areas of science, particularly human genetics, means he is perfectly-placed to provide the insight and challenge we need as GSK moves further into developing next generation medicines and vaccines for patients.”. Dr Hal Dietz is Victor A. GSK is a science-led global healthcare company.

Genetics 52

Genetics Medicine Cardiology Scientist 52

The Pharma Data

NOVEMBER 17, 2020

“Younger people often think they’re invincible from COVID, but we wanted to find out if that was really true,” said Hendren, a cardiology fellow at UT Southwestern Medical Center in Dallas. The study looked at data from patients hospitalized with COVID-19 at 88 U.S.

Vaccine 52

Vaccine Vaccination Cardiology Research 52

The Pharma Data

NOVEMBER 4, 2020

You must receive meningococcal vaccines at least 2 weeks before your first dose of ULTOMIRIS if you are not vaccinated. If your doctor decided that urgent treatment with ULTOMIRIS is needed, you should receive meningococcal vaccination as soon as possible. Your doctor will decide if you need additional vaccination.

Doctor 52

Doctor Doctors Vaccine Vaccination 52

The Pharma Data

MAY 13, 2021

Journal of the American College of Cardiology. DOI: 10.1111/adb.12134. Malik VS, Hu FB. Fructose and Cardiometabolic Health: What the Evidence from Sugar-Sweetened Beverages Tells Us. 2015;66(14):1615-1624. DOI: 10.1016/j.jacc.2015.08.025. 2015.08.025. . Mason AE, Epel ES, Aschbacher K, et al.

Insulin 52

Insulin Production Hormones Medicine 52